Potential urinary biomarkers of disease activity in Crohn's disease

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 12, 2010, Pages 1440-1448

  Markó, Lajos ^a   Szigeti, Nóra ^a   Szabó, Zoltán ^b   Böddi, Katalin ^b   Takátsy, Anikó ^b   Ludány, Andrea ^b   Kószegi, Tamás ^b   Molnár, Gergó A ^a   Wittmann, István ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Alpha 1 acid glycoprotein; Biomarker; Crohn's disease; Zinc alpha 2 glycoprotein

Indexed keywords

ALBUMIN; ALPHA2 GLYCOPROTEIN; AZATHIOPRINE; GLYCOPROTEIN; MESALAZINE; METHYLPREDNISOLONE; OROSOMUCOID;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE EXACERBATION; FOLLOW UP; GEL ELECTROPHORESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PILOT STUDY; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TURBIDIMETRY;

EID: 78649249666     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2010.505658     Document Type: Article

References (28)

1. Nikolaus S, Schreiber S. Diagnostics of inflammatory bowel disease. Gastroenterology 2007;133:1670-89.
2. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 2006;55:426-31.
3. Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987;31:673-89.
4. Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ. Microalbuminuria predicts mortality in noninsulin-dependent diabetics. Diabet Med 1984;1:17-19.
5. Messent JW, Elliott TG, Hill RD, Jarrett RJ, Keen H, Viberti GC. Prognostic significance of microalbuminuria in insulin dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int 1992;41:836-9.
6. Hillege HL, Janssen WM, Bak AA, Diercks GF, Grobbee DE, Crijns HJ, et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 2001;249:519-26.
7. Mahmud N, Stinson J, O'Connell MA, Mantle TJ, Keeling PW, Feely J, et al. Microalbuminuria in inflammatory bowel disease. Gut 1994;35:1599-604.
8. Mahmud N, McDonald GS, Kelleher D, Weir DG. Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease. Gut 1996;38:99-103.
9. Mahmud N, O'Connell MA, Stinson J, Goggins MG, Weir DG, Kelleher D. Tumour necrosis factor-alpha and microalbuminuria in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995;7:215-19.
10. Comper WD, Osicka TM, Jerums G. High prevalence of immunounreactive intact albumin in urine of diabetic patients. Am J Kidney Dis 2003;41:336-42.
11. Osicka TM, Comper WD. Characterization of immunochemically nonreactive urinary albumin. Clin Chem 2004;50:2286-91.
12. Comper WD, Haraldsson B, Deen WM. Resolved: normal glomeruli filter nephrotic levels of albumin. J Am Soc Nephrol 2008;19:427-32.
13. Szigeti N, Markó L, Molnár GA, Fábián G, Cseh J, Mohás M, et al. Microalbuminuria in inflammatory bowel diseases using immunoturbidimetry and high-performance liquid chromatography. Acta Gastroenterol Belg 2009;72:394-401.
14. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19 Suppl: A5-36.
15. Best WR. Predicting the Crohn's disease activity index from the Harvey-Bradshaw index. Inflamm Bowel Dis 2006;12:304-10.
16. Takátsy A, Böddi K, Nagy L, Nagy G, Szabó S, Markó L, et al. Enrichment of Amadori products derived from the nonenzymatic glycation of proteins using microscale boronate affinity chromatography. Anal Biochem 2009;393:8-22.
17. Laemmli UK. Cleavage of structural proteins during assembly of the head bacteriophage T4. Nature 1970;27:680-5.
18. Willoughby EW. A sensitive silver stain for protein in agarose gel. Anal Biochem 1983;130:353-8.
19. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 2006;1:2856-60.
20. Candiano G, Musante L, Bruschi M, Petretto A, Santucci L, Del Boccio P, et al. Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. J Am Soc Nephrol 2006;17:3139-48.
21. Brinkman JW, Bakker SJ, Gansevoort RT, Hillege HL, Kema IP, Gans RO, et al. Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC. Kidney Int Suppl 2004;92: S69-S75.
22. Comper WD, Osicka TM, Clark M, MacIsaac RJ, Jerums G. Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay. Kidney Int 2004;65:1850-5.
23. Hochepied T, Wullaert A, Berger FG, Baumann H, Brouckaert P, Steidler L, et al. Overexpression of alpha (1)-acid glycoprotein in transgenic mice leads to sensitisation to acute colitis. Gut 2002;51:398-404.
24. Christiansen MS, Hommel E, Magid E, Feldt-Rasmussen B. Orosomucoid in urine is a powerful predictor of cardiovascular mortality in normoalbuminuric patients with type 2 diabetes at five years of follow-up. Diabetologia 2005;48:386-93.
25. McDermott LC, Freel JA, West AP, Bjorkman PJ, Kennedy MW. Zn-alpha2-glycoprotein, an MHC class I-related glycoprotein regulator of adipose tissues: modification or abrogation of ligand binding by site-directed mutagenesis. Biochemistry 2006;45:2035-41.
26. Hassan MI, Waheed A, Yadav S, Singh TP, Ahmad F. Zinc alpha 2-glycoprotein: a multidisciplinary protein. Mol Cancer Res 2008;6:892-906.
27. Sviridov D, Meilinger B, Drake SK, Hoehn GT, Hortin GL. Coelution of other proteins with albumin during sizeexclusion HPLC Implications for analysis of urinary albumin. Clin Chem 2006;52:389-97.
28. Markó L, Molnár GA, Wagner Z, Böddi K, Koszegi T, Szabó Z, et al. Measurement of the modification and interference rate of urinary albumin detected by size-exclusion HPLC. Physiol Meas 2009;30:1137-50.